Use of enoxaparin for the chronically anticoagulated patient before and after procedures - 08/09/11
Doi : 10.1016/S0002-9149(99)00341-0
John M Spandorfer, MD a, ⁎, Susan Lynch, RN a, Howard H Weitz, MD b, Scott Fertel b : DO, Geno J Merli, MD a
a Division of Internal Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA
b Division of Cardiology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA
*Dr. Spandorfer’s address is: 211 South 9th Street, Philadelphia, Pennsylvania 19107
 | This study was supported in part by a research grant from Rhone-Poulenc Rorer, Collegeville, Pennsylvania. |
© 1999
Excerpta Medica Inc. Tous droits réservés.
Vol 84 - N° 4
P. 478-480 - août 1999 Retour au numéro
Article précédent
- Effect of vasoactive therapy on heart rate variability in patients with acutely decompensated congestive heart failure
- Andrew J Burger, Doron Aronson
- Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension
- Alan L Hinderliter, Park W Willis, Walker Long, William R Clarke, David Ralph, Edgar J Caldwell, William Williams, Neil A Ettinger, Nicholas S Hill, Warren R Summer, Bennett de Boisblanc, Gary Koch, Shu Li, Linda M Clayton, Maria M Jöbsis, James W Crow, for the PPH Study Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?